Edition:
United States

China Biologic Products Inc (CBPO.OQ)

CBPO.OQ on NASDAQ Stock Exchange Global Select Market

114.08USD
21 Apr 2017
Change (% chg)

$-1.06 (-0.92%)
Prev Close
$115.14
Open
$115.39
Day's High
$115.39
Day's Low
$113.27
Volume
164,659
Avg. Vol
65,975
52-wk High
$136.50
52-wk Low
$97.05

Latest Key Developments (Source: Significant Developments)

China Biologic Q4 adjusted non-GAAP earnings per share $0.95
Thursday, 23 Feb 2017 05:00pm EST 

China Biologic Products Inc : China Biologic reports financial results for the fourth quarter and fiscal year 2016 . Q4 adjusted non-GAAP earnings per share $0.95 . Q4 earnings per share $0.69 . Q4 sales rose 13.6 percent to $77.6 million . China Biologic Products says expects total sales to grow 13% to 15% in RMB terms for 2017 .China Biologic Products Inc sees 2017 non-GAAP adjusted net income to grow 18% to 20% in RMB terms.  Full Article

Baillie Gifford & Co reports 5.21 pct passive stake in China Biologic Products
Friday, 13 Jan 2017 09:04am EST 

China Biologic Products Inc :Baillie Gifford & Co reports 5.21 percent passive stake in China Biologic Products Inc as of december 31 - sec filing.  Full Article

China Biologic Products says reiterates its full year forecast of total sales growth
Wednesday, 4 Jan 2017 08:30am EST 

China Biologic Products Inc : China Biologic Products says reiterates its full year forecast of total sales growth of 22 pct to 24 pct in rmb terms . China Biologic Products says reiterates its full year forecast of non-GAAP adjusted net income growth of 33 pct to 35 pct in rmb terms .China Biologic Products sees total sales,non-GAAP adjusted net income in USD terms in 2016 will be adversely affected by foreign currency translation impact.  Full Article

China Biologic acquires full ownership of Guizhou Taibang
Wednesday, 26 Oct 2016 08:30am EDT 

China Biologic Products Inc : China Biologic Products Inc - deal for $62.1 million . China biologic - Guizhou Taibang has become a wholly owned subsidiary of company . China biologic - Guizhou Taibang paid first installment of RMB90 million of consideration to former minority shareholders in August 2016 .Guizhou Taibang will pay balance of consideration in accordance with agreement.  Full Article

China Biologic says Min Fang resigned directorship
Monday, 15 Aug 2016 08:30am EDT 

China Biologic Products - : China Biologic announces change to board of directors . Min Fang, director associated with Warburg Pincus LLC, resigned his directorship of co with effect from August 15, 2016. .Warburg Pincus has reduced its holdings in company over last year and now hold less than 0.1% of co's outstanding common stock.  Full Article

Capital Research Global Investors reports 11.3 pct passive stake in China Biologic Products
Friday, 8 Jul 2016 01:40pm EDT 

:Capital Research Global Investors reports a passive stake of 11.3% in China Biologic Products Inc as of June 30, 2016 - SEC Filing.  Full Article

China Biologic Products says secondary offering of 2.78 mln common shares
Thursday, 2 Jun 2016 04:53pm EDT 

China Biologic Products Inc : Says secondary offering 2.78 million common shares .China Biologic announces secondary offering of common stock.  Full Article

China Biologic Products Inc announces pricing of secondary offering of common stock
Wednesday, 2 Mar 2016 09:17am EST 

China Biologic Products Inc:Pricing of a secondary offering of 3,870,000 shares of common stock at a price to public of $110 per share.  Full Article

China Biologic Products Inc enters into strategic collaboration agreement to source raw materials
Wednesday, 2 Sep 2015 08:30am EDT 

China Biologic Products Inc:Announces that the Company's subsidiary Guizhou Taibang Biological Products Co., Ltd entered into a strategic collaboration agreement with Xinjiang Deyuan Bioengineering Co., Ltd. to source raw plasma.Says the Agreement allows Guizhou Taibang to source no less than 500 tonnes of source plasma from Xinjiang Deyuan over the next three years.  Full Article

China Biologic Products Inc gives Q3, Q4 2015 revenue outlook; reaffirms FY 2015 outlook
Wednesday, 5 Aug 2015 05:00pm EDT 

China Biologic Products Inc:Expects year-over-year Q3 2015 sales growth rate to be lower than the first two quarters of 2015, primarily due to a relatively high volume sold in the Q3 2014 after receiving the first batch approval in July 2014 at the upgraded Guizhou facility.Expect year-over-year Q4 2015 sales growth rate to increase over the Q3 2015 as benefit from the sales of products made from purchased plasma.Reiterates FY 2015 sales and non-GAAP adjusted net income forecast.Expects FY 2015 Total sales to be in the range of $290 to $295 million.Expects FY 2015 non-GAAP adjusted net income to be in the range of $95 to $97 million.Q3 2015 revenue of $82.06 mln - Thomson Reuters I/B/E/S.Q4 2015 revenue of $69.13 mln - Thomson Reuters I/B/E/S.FY 2015 revenue of $294 mln - Thomson Reuters I/B/E/S.  Full Article

More From Around the Web

BRIEF-China Biologic Q4 adjusted non-GAAP earnings per share $0.95

* China Biologic reports financial results for the fourth quarter and fiscal year 2016